+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Therapeutics Market 2019-2025

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129673
Global Dermatological Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-infectives, Corticosteroids, Calcineurin Inhibitors, Retinoids, and Others), By Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Metastatic Malignant Melanoma, and Others), and Forecast 2019-2025.

The global psoriasis market is estimated to grow significantly during the forecast period. The primary factors that drive the growth of the market include the rising geriatric population across the globe. As people age, they are more prone to developing skin-related disorders due to factors such as lifestyle changes, reduced skin strength and elasticity, and lower sebaceous gland secretions. The increased occurrence of dermatological illnesses and increased awareness regarding the development of the skin-related disease, etiology, and availability of several therapies are some of the key factors to drive the global dermatological therapeutics market growth. However, lack of awareness among the peoples especially in emerging economies along with the higher prices is some of the factors that hamper the growth of the market during the forecast period.

The global dermatological therapeutics market is segmented on the basis of drug class and application. Based on the drug class, the market is segmented intoanti-infectives, corticosteroids, calcineurin inhibitors, retinoids, and others. Corticosteroids are projected to hold significant market share. Based on the application, the market is segmented into alopecia, herpes, psoriasis, rosacea, atopic dermatitis, metastatic malignant melanoma, and others. Atopic dermatitis is projected to grow at a considerable rate during the forecast period.

Further, AbbVie Inc., Allergan PLC., Amgen Inc., ., Johnson & Johnson Services Inc., Novartis International AG,Eli Lilly & Co., and LEO Pharma A/Sare some of the prominent players operating in the global dermatological therapeutics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For instance, in December 2019, Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, signed a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in Phase 2 development for the treatment of atopic dermatitis and hidradenitis suppurativa.

Research Methodology

The market study of the global dermatological therapeutics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for dermatological drugs manufacturers, pharmaceutical companies, contract manufacturers, raw material suppliers, industry associations &experts, research institutes, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Dermatological Therapeutics Market Research and Analysis by Drug Class
2. Global Dermatological Therapeutics Market Research and Analysis by Application

The Report covers:
  • Comprehensive research methodology of the global dermatological therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global dermatological therapeutics market.
  • Insights about market determinants which are stimulating the global dermatological therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Amgen Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.2.2. Novartis International AG Overview Financial Analysis SWOT Analysis Recent Developments
3.2.3. Abbvie Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.2.4. Allergan PLC Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Dermatological Therapeutics Market by Drug Class
5.1.1. Anti-infectives
5.1.2. Corticosteroids
5.1.3. Calcineurin Inhibitors
5.1.4. Retinoids
5.1.5. Others
5.2. Global Dermatological Therapeutics Market by Application
5.2.1. Alopecia
5.2.2. Herpes
5.2.3. Psoriasis
5.2.4. Rosacea
5.2.5. Atopic Dermatitis
5.2.6. Metastatic Malignant Melanoma
5.2.7. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Aclaris Therapeutics, Inc.
7.3. Allergan PLC
7.4. Almirall SA
7.5. Amgen Inc.
7.6. Aurobindo Pharma Ltd.
7.7. Bausch Health Companies Inc.
7.8. Cipher Pharmaceuticals Inc.
7.9. Eli Lilly & Co.
7.10. Galderma SA
7.11. GlaxoSmithKline PLC
7.12. Glenmark Pharmaceuticals Ltd.
7.13. Johnson & Johnson Services Inc.
7.14. LEO Pharma A/S
7.15. Novartis International AG
7.16. Pfizer Inc.
7.17. Sanofi SA
7.18. Sun Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • Allergan PLC
  • Almirall SA
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Cipher Pharmaceuticals Inc.
  • Eli Lilly & Co.
  • Galderma SA
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson Services Inc.
  • LEO Pharma A/S
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.